278 related articles for article (PubMed ID: 22495042)
1. [The clinical value of 3 tesla diffusion-weighted magnetic resonance imaging in the diagnosis of prostate cancer].
Shimamoto T; Ashida S; Yamasaki I; Kuno T; Fukuhara H; Fukata S; Satake H; Tamura K; Karashima T; Kamata M; Inoue K; Shuin T; Kariya S; Ogawa Y
Hinyokika Kiyo; 2012 Mar; 58(3):143-8. PubMed ID: 22495042
[TBL] [Abstract][Full Text] [Related]
2. Prediction of locally recurrent prostate cancer after radiation therapy: incremental value of 3T diffusion-weighted MRI.
Kim CK; Park BK; Lee HM
J Magn Reson Imaging; 2009 Feb; 29(2):391-7. PubMed ID: 19161194
[TBL] [Abstract][Full Text] [Related]
3. Prostate cancer detection: comparison of T2-weighted imaging, diffusion-weighted imaging, proton magnetic resonance spectroscopic imaging, and the three techniques combined.
Chen M; Dang HD; Wang JY; Zhou C; Li SY; Wang WC; Zhao WF; Yang ZH; Zhong CY; Li GZ
Acta Radiol; 2008 Jun; 49(5):602-10. PubMed ID: 18568549
[TBL] [Abstract][Full Text] [Related]
4. Value of diffusion-weighted imaging for the prediction of prostate cancer location at 3T using a phased-array coil: preliminary results.
Kim CK; Park BK; Lee HM; Kwon GY
Invest Radiol; 2007 Dec; 42(12):842-7. PubMed ID: 18007156
[TBL] [Abstract][Full Text] [Related]
5. Detection of prostate cancer with magnetic resonance imaging: optimization of T1-weighted, T2-weighted, dynamic-enhanced T1-weighted, diffusion-weighted imaging apparent diffusion coefficient mapping sequences and MR spectroscopy, correlated with biopsy and histopathological findings.
Aydin H; Kizilgöz V; Tatar IG; Damar C; Ugan AR; Paker I; Hekimoğlu B
J Comput Assist Tomogr; 2012; 36(1):30-45. PubMed ID: 22261768
[TBL] [Abstract][Full Text] [Related]
6. High-b-value diffusion-weighted imaging at 3 T to detect prostate cancer: comparisons between b values of 1,000 and 2,000 s/mm2.
Kim CK; Park BK; Kim B
AJR Am J Roentgenol; 2010 Jan; 194(1):W33-7. PubMed ID: 20028888
[TBL] [Abstract][Full Text] [Related]
7. In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissue using thin-slice echo-planar imaging.
Manenti G; Squillaci E; Di Roma M; Carlani M; Mancino S; Simonetti G
Radiol Med; 2006 Dec; 111(8):1124-33. PubMed ID: 17171522
[TBL] [Abstract][Full Text] [Related]
8. Lesion localization in patients with a previous negative transrectal ultrasound biopsy and persistently elevated prostate specific antigen level using diffusion-weighted imaging at three Tesla before rebiopsy.
Park BK; Lee HM; Kim CK; Choi HY; Park JW
Invest Radiol; 2008 Nov; 43(11):789-93. PubMed ID: 18923258
[TBL] [Abstract][Full Text] [Related]
9. Diffusion-weighted MRI of peripheral zone prostate cancer: comparison of tumor apparent diffusion coefficient with Gleason score and percentage of tumor on core biopsy.
Woodfield CA; Tung GA; Grand DJ; Pezzullo JA; Machan JT; Renzulli JF
AJR Am J Roentgenol; 2010 Apr; 194(4):W316-22. PubMed ID: 20308476
[TBL] [Abstract][Full Text] [Related]
10. The value of diffusion-weighted MRI for prostate cancer detection and localization.
Yağci AB; Ozari N; Aybek Z; Düzcan E
Diagn Interv Radiol; 2011 Jun; 17(2):130-4. PubMed ID: 20694948
[TBL] [Abstract][Full Text] [Related]
11. Prostate cancer: utility of diffusion-weighted imaging as a marker of side-specific risk of extracapsular extension.
Rosenkrantz AB; Chandarana H; Gilet A; Deng FM; Babb JS; Melamed J; Taneja SS
J Magn Reson Imaging; 2013 Aug; 38(2):312-9. PubMed ID: 23238968
[TBL] [Abstract][Full Text] [Related]
12. Prostate cancer: comparison of tumor visibility on trace diffusion-weighted images and the apparent diffusion coefficient map.
Rosenkrantz AB; Kong X; Niver BE; Berkman DS; Melamed J; Babb JS; Taneja SS
AJR Am J Roentgenol; 2011 Jan; 196(1):123-9. PubMed ID: 21178056
[TBL] [Abstract][Full Text] [Related]
13. [Utility of diffusion-weighted magnetic resonance imaging and apparent diffusion coefficient in detection of prostate cancer and prediction of pathologic Gleason score].
Kagebayashi Y; Nakai Y; Matsumoto Y; Samma S; Miyasaka T; Nakagawa H
Hinyokika Kiyo; 2012 Aug; 58(8):405-8. PubMed ID: 23052263
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of prebiopsy multifunctional and morphologic MRI combined with free-to-total prostate-specific antigen ratio in the detection of prostate cancer.
Vilanova JC; Barceló-Vidal C; Comet J; Boada M; Barceló J; Ferrer J; Albanell J
AJR Am J Roentgenol; 2011 Jun; 196(6):W715-22. PubMed ID: 21606259
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of diffusion-weighted imaging in the localization of prostate cancer.
Kajihara H; Hayashida Y; Murakami R; Katahira K; Nishimura R; Hamada Y; Kitani K; Kitaoka M; Suzuki Y; Kitajima M; Hirai T; Morishita S; Awai K; Yamashita Y
Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):399-403. PubMed ID: 19019564
[TBL] [Abstract][Full Text] [Related]
16. Diffusion-weighted imaging of the prostate at 3 T for differentiation of malignant and benign tissue in transition and peripheral zones: preliminary results.
Kim CK; Park BK; Han JJ; Kang TW; Lee HM
J Comput Assist Tomogr; 2007; 31(3):449-54. PubMed ID: 17538295
[TBL] [Abstract][Full Text] [Related]
17. Assessment of response to radiotherapy for prostate cancer: value of diffusion-weighted MRI at 3 T.
Song I; Kim CK; Park BK; Park W
AJR Am J Roentgenol; 2010 Jun; 194(6):W477-82. PubMed ID: 20489065
[TBL] [Abstract][Full Text] [Related]
18. Diffusion-weighted magnetic resonance imaging of breast lesions: first experiences at 3 T.
Lo GG; Ai V; Chan JK; Li KW; Cheung PS; Wong TT; Ma M; Lee R; Chien D
J Comput Assist Tomogr; 2009; 33(1):63-9. PubMed ID: 19188787
[TBL] [Abstract][Full Text] [Related]
19. Correlation between metabolite ratios and ADC values of prostate in men with increased PSA level.
Kumar V; Jagannathan NR; Kumar R; Das SC; Jindal L; Thulkar S; Gupta SD; Dwivedi SN; Roell S; Hemal AK; Gupta NP
Magn Reson Imaging; 2006 Jun; 24(5):541-8. PubMed ID: 16735174
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]